Evidence map›Paper›PMID 40710457›Full record

ReviewJournal of functional biomaterials2025

Photothermal Release by Melanin-like Nanoparticles: Biomedical Applications.

Arianna Menichetti, Silvia Vicenzi, Agata Pane, Dario Mordini, Fabrizio Mancin, Marco Montalti

Abstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arianna MenichettiDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0000-0003-0895-4776
Silvia VicenziDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0009-0002-2160-0040
Agata PaneDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.
Dario MordiniDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0000-0002-8084-4638
Fabrizio MancinDepartment of Chemical Sciences, University of Bologna, Via Marzolo 1, 35131 Padova, Italy.ORCID 0000-0003-0786-0364
Marco MontaltiDepartment of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0000-0001-6227-0899

Funding

MIUR P20224N3WK
6 · The paper itself

Abstract

Melanin-like nanoparticles (NPs) exhibit a remarkable ability to absorb light across a wide range of wavelengths, from the ultraviolet (UV) to the near-infrared (NIR) spectrum. This characteristic enables them to serve as effective photothermal agents (PTAs). Upon irradiation, especially within the NIR window, a region where biological tissues are highly transparent, these NPs efficiently convert light energy into heat. This phenomenon, known as the photothermal effect, leads to localized temperature increases. The resulting heat can be strategically employed to induce selective cell death in photothermal therapy (PTT) or to enhance the release of therapeutic agents directly from the NPs. The inherent versatility of melanin-like NPs, stemming from their synthesis methods and the presence of various functional groups, allows for straightforward loading with drugs or other bioactive molecules. Consequently, they are attractive tools for photothermally activated release. This review paper thoroughly examines and critically discusses the latest applications of melanin-like NPs in photothermally controlled release. We dedicate a specific section to general mechanisms and approaches, and this paper concludes with an analysis of critical challenges and prospective future developments.

Indexed as

antioxidantscontrolled releasedrug deliverymultimodalnanomedicinePDTphototherapyPTTsynergistic therapytheragnostic

Identifiers

PMID40710457
PMCPMC12295729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.